DIVA Laboratories (Taiwan) Insiders
| 4153 Stock | TWD 33.50 0.35 1.03% |
DIVA Laboratories employs about 28 people. The company is managed by 7 executives with a total tenure of roughly 66 years, averaging almost 9.0 years of service per executive, having 4.0 employees per reported executive. Recap of DIVA Laboratories' management performance can provide insight into the venture performance.
| Su Lin Insider Accounting Supervisor |
| Gene Chen Insider Chairman CEO |
DIVA |
DIVA Laboratories Management Team Effectiveness
The company has return on total asset (ROA) of 0.0184 % which means that it generated a profit of $0.0184 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0277 %, meaning that it generated $0.0277 on every $100 dollars invested by stockholders. DIVA Laboratories' management efficiency ratios could be used to measure how well DIVA Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.DIVA Laboratories holds a total of 58.67 Million outstanding shares. DIVA Laboratories shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.86 percent of DIVA Laboratories outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as DIVA Laboratories in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of DIVA Laboratories, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
DIVA Laboratories Workforce Comparison
DIVA Laboratories is number one stock in number of employees category among its peers. The total workforce of Diagnostics & Research industry is presently estimated at about 665. DIVA Laboratories holds roughly 28.0 in number of employees claiming about 4% of equities under Diagnostics & Research industry.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04. DIVA Laboratories Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. DIVA Laboratories Price Series Summation is a cross summation of DIVA Laboratories price series and its benchmark/peer.
DIVA Laboratories Notable Stakeholders
A DIVA Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DIVA Laboratories often face trade-offs trying to please all of them. DIVA Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DIVA Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Su Lin | Accounting Supervisor | Profile | |
| Gene Chen | Chairman CEO | Profile | |
| Jun Li | Director Department | Profile | |
| Jian Zhang | Deputy Director | Profile | |
| James Chen | VP CTO | Profile | |
| Peter Chang | Chief Officer | Profile | |
| Kenneth Chen | Chief SO | Profile |
About DIVA Laboratories Management Performance
The success or failure of an entity such as DIVA Laboratories often depends on how effective the management is. DIVA Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DIVA management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DIVA management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in DIVA Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DIVA Laboratories. Check DIVA Laboratories' Beneish M Score to see the likelihood of DIVA Laboratories' management manipulating its earnings.
DIVA Laboratories Workforce Analysis
Traditionally, organizations such as DIVA Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DIVA Laboratories within its industry.DIVA Laboratories Manpower Efficiency
Return on DIVA Laboratories Manpower
| Revenue Per Employee | 25.4M | |
| Revenue Per Executive | 101.7M | |
| Net Income Per Employee | 780.5K | |
| Net Income Per Executive | 3.1M |
Additional Tools for DIVA Stock Analysis
When running DIVA Laboratories' price analysis, check to measure DIVA Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DIVA Laboratories is operating at the current time. Most of DIVA Laboratories' value examination focuses on studying past and present price action to predict the probability of DIVA Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DIVA Laboratories' price. Additionally, you may evaluate how the addition of DIVA Laboratories to your portfolios can decrease your overall portfolio volatility.